Empress Therapeutics

About:

Empress Therapeutics is to generate transformative drug candidates that get to the clinic faster and cheaper.

Website: http://www.empresstx.com

Twitter/X: Empress_Tx

Top Investors: Flagship Pioneering

Description:

Empress Therapeutics is a biotechnology business in its early stages focused on drug development and new molecular insights into health and illness. The company's proprietary bio platform uses evolution, human molecular and genetic data, and artificial intelligence to identify advanced starting points in endogenous drug-like molecules, allowing clinicians to treat a wide range of serious unmet medical needs with small-molecule drug candidates.

Total Funding Amount:

$50M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2022-01-01

Founders:

Jason Park

Number of Employees:

11-50

Last Funding Date:

2023-06-21

IPO Status:

Private

© 2024 MyAiNote.com